Genprex, Inc. (GNPX): Price and Financial Metrics
GNPX Price/Volume Stats
Current price | $0.47 | 52-week high | $5.41 |
Prev. close | $0.48 | 52-week low | $0.28 |
Day low | $0.41 | Volume | 16,734,559 |
Day high | $0.55 | Avg. volume | 898,648 |
50-day MA | $0.80 | Dividend yield | N/A |
200-day MA | $1.35 | Market Cap | 4.01M |
GNPX Stock Price Chart Interactive Chart >
Genprex, Inc. (GNPX) Company Bio
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.
GNPX Price Returns
1-mo | -36.31% |
3-mo | -70.63% |
6-mo | -27.47% |
1-year | -89.89% |
3-year | -99.47% |
5-year | -99.73% |
YTD | -44.81% |
2024 | -90.74% |
2023 | -84.14% |
2022 | 10.69% |
2021 | -68.43% |
2020 | 1,196.88% |
Loading social stream, please wait...